Samuel Singer
Physician · Northwell Health
Credentials: · · · ·
History
- 2023–Present
- 2010–2012
Medical Oncology
- 2007–2010
Neurology
2003–2007
Research
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
New England Journal of Medicine · 2002 · 3,431 citations
The landscape of somatic copy-number alteration across human cancers
Nature · 2010 · 3,217 citations
PDGFRA activating mutations in gastrointestinal stromal tumors
Science · 2003 · 1,890 citations
- CA
107 papers
- MB
64 papers
- WT
59 papers
- AC
40 papers · 3 as a fellow
- RM
40 papers
- PC
35 papers
- MD
33 papers
- MK
31 papers
Grants
- 2018–2029
National Cancer Institute · P50
Contact PI · $19M · Sloan-Kettering Inst Can Research
- 2010–2018
National Cancer Institute · P50
Contact PI · $11.1M · Sloan-Kettering Inst Can Research
- 1997–2012
Soft Tissue Sarcoma Program Project
National Cancer Institute · P01
Contact PI · $8.8M · Sloan-Kettering Inst Can Research
- 2010–2011
ACQUISITION OF A SOLiD 3 SEQUENCER
National Center for Research Resources · S10
PI · $425K · Sloan-Kettering Inst Can Research
Clinical trials
- 2009
Application of Magnetic Resonance Fat-Free Imaging
Principal investigator · Terminated
Memorial Sloan Kettering Cancer Center
- 2003–2005
Principal investigator · Completed · Phase 3
Memorial Sloan Kettering Cancer Center